Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Stomatitis 2Squamous Cell Carcinoma of Head and Neck 1Head and Neck Neoplasms 1Esophagitis 1

Interventions

avasopasem manganese 1Surgical Procedures, Operative 1Radiation 1Induction Chemotherapy 1Heart Rate 1Drug Therapy 1Amifostine 1Alginates 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Esophagitis × avasopasem manganese × Clear all
NCT04225026 2023-03-23

Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis Due to Chemoradiotherapy for Lung Cancer

Galera Therapeutics, Inc.

Phase 2 Terminated
39 enrolled 12 charts

Esophagitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡